VKTX insider transactions
Viking Therapeutics Inc. (VKTX) Form 4 insider transactions - real-time wire coverage of every officer, director, and 10% owner trade.
Recent Form 3, 4, and 5 filings for VKTX
- SEC Form 4 filed by Chief Medical Officer Chen Hubert C4 - Viking Therapeutics, Inc. (0001607678) (Issuer)
- SEC Form 3 filed by new insider Chen Hubert C3 - Viking Therapeutics, Inc. (0001607678) (Issuer)
- SEC Form 4 filed by Viking Therapeutics Inc.4 - Viking Therapeutics, Inc. (0001607678) (Issuer)
- SEC Form 4 filed by Chief Commercial Officer Aubuchon Neil William4 - Viking Therapeutics, Inc. (0001607678) (Issuer)
- SEC Form 3 filed by new insider Aubuchon Neil William3 - Viking Therapeutics, Inc. (0001607678) (Issuer)
- Chief Financial Officer Zante Greg was granted 73,049 shares and sold $1,896,969 worth of shares (57,661 units at $32.90), increasing direct ownership by 9% to 189,891 units (SEC Form 4)4 - Viking Therapeutics, Inc. (0001607678) (Issuer)
- Chief Operating Officer Mancini Marianna was granted 73,049 shares and sold $1,901,405 worth of shares (57,661 units at $32.98), increasing direct ownership by 4% to 409,190 units (SEC Form 4)4 - Viking Therapeutics, Inc. (0001607678) (Issuer)
- President & CEO Lian Brian sold $7,692,121 worth of shares (233,409 units at $32.96) and was granted 302,480 shares, increasing direct ownership by 3% to 2,499,291 units (SEC Form 4)4 - Viking Therapeutics, Inc. (0001607678) (Issuer)
- Director Singleton J Matthew was granted 3,150 shares, increasing direct ownership by 33% to 12,650 units (SEC Form 4)4 - Viking Therapeutics, Inc. (0001607678) (Issuer)
- Director Macartney Lawson was granted 3,150 shares, increasing direct ownership by 7% to 51,115 units (SEC Form 4)4 - Viking Therapeutics, Inc. (0001607678) (Issuer)
- Director Rowland Charles A Jr was granted 3,150 shares, increasing direct ownership by 10% to 33,150 units (SEC Form 4)4 - Viking Therapeutics, Inc. (0001607678) (Issuer)
- Director Foehr Matthew W exercised 16,000 shares at a strike of $3.33, sold $561,694 worth of shares (16,000 units at $35.11) and was granted 3,150 shares, increasing direct ownership by 2% to 135,186 units (SEC Form 4)4 - Viking Therapeutics, Inc. (0001607678) (Issuer)
- Director Rouan Sarah Kathryn was granted 3,150 shares, increasing direct ownership by 254% to 4,390 units (SEC Form 4)4 - Viking Therapeutics, Inc. (0001607678) (Issuer)
- Chief Operating Officer Mancini Marianna was granted 11,117 shares and sold $216,492 worth of shares (6,185 units at $35.00), increasing direct ownership by 1% to 382,467 units (SEC Form 4)4 - Viking Therapeutics, Inc. (0001607678) (Issuer)
- Director Rowland Charles A Jr sold $2,134,278 worth of shares (60,000 units at $35.57) and was granted 60,000 shares (SEC Form 4)4 - Viking Therapeutics, Inc. (0001607678) (Issuer)
- President & CEO Lian Brian was granted 70,084 shares and sold $1,364,923 worth of shares (38,989 units at $35.01), increasing direct ownership by 1% to 2,419,109 units (SEC Form 4)4 - Viking Therapeutics, Inc. (0001607678) (Issuer)
- Chief Financial Officer Zante Greg was granted 11,117 shares and sold $216,481 worth of shares (6,185 units at $35.00), increasing direct ownership by 3% to 173,592 units (SEC Form 4)4 - Viking Therapeutics, Inc. (0001607678) (Issuer)
- Chief Financial Officer Zante Greg was granted 7,667 shares and sold $118,428 worth of shares (4,266 units at $27.76), increasing direct ownership by 2% to 168,660 units (SEC Form 4)4 - Viking Therapeutics, Inc. (0001607678) (Issuer)
- President & CEO Lian Brian was granted 48,333 shares and sold $747,633 worth of shares (26,889 units at $27.80), increasing direct ownership by 0.91% to 2,388,014 units (SEC Form 4)4 - Viking Therapeutics, Inc. (0001607678) (Issuer)
- Chief Operating Officer Mancini Marianna sold $118,473 worth of shares (4,266 units at $27.77) and was granted 7,667 shares, increasing direct ownership by 0.91% to 377,535 units (SEC Form 4)4 - Viking Therapeutics, Inc. (0001607678) (Issuer)
- Director Foehr Matthew W exercised 20,786 shares at a strike of $8.00, increasing direct ownership by 19% to 132,036 units (SEC Form 4)4 - Viking Therapeutics, Inc. (0001607678) (Issuer)
- Amendment: Director Rouan Sarah Kathryn bought $29,943 worth of shares (1,240 units at $24.15) (SEC Form 4)4/A - Viking Therapeutics, Inc. (0001607678) (Issuer)
- Director Rouan Sarah Kathryn bought $29,943 worth of shares (1,240 units at $24.15) (SEC Form 4)4 - Viking Therapeutics, Inc. (0001607678) (Issuer)
- President & CEO Lian Brian was granted 256,133 shares and sold $8,313,601 worth of shares (194,490 units at $42.75), increasing direct ownership by 3% to 2,366,570 units (SEC Form 4)4 - Viking Therapeutics, Inc. (0001607678) (Issuer)
- Chief Operating Officer Mancini Marianna was granted 66,200 shares and sold $2,317,599 worth of shares (54,215 units at $42.75), increasing direct ownership by 3% to 374,134 units (SEC Form 4)4 - Viking Therapeutics, Inc. (0001607678) (Issuer)
- Chief Financial Officer Zante Greg sold $2,150,595 worth of shares (50,309 units at $42.75) and was granted 66,200 shares, increasing direct ownership by 11% to 165,259 units (SEC Form 4)4 - Viking Therapeutics, Inc. (0001607678) (Issuer)
- SEC Form 4 filed by Director Macartney Lawson4 - Viking Therapeutics, Inc. (0001607678) (Issuer)
- SEC Form 4 filed by Director Singleton J Matthew4 - Viking Therapeutics, Inc. (0001607678) (Issuer)
- SEC Form 4 filed by Director Rowland Charles A Jr4 - Viking Therapeutics, Inc. (0001607678) (Issuer)
- SEC Form 4 filed by Director Foehr Matthew W4 - Viking Therapeutics, Inc. (0001607678) (Issuer)
- SEC Form 4 filed by Director Rouan Sarah Kathryn4 - Viking Therapeutics, Inc. (0001607678) (Issuer)
- Director Macartney Lawson exercised 2,000 shares at a strike of $5.80 and sold $137,333 worth of shares (2,000 units at $68.67) (SEC Form 4)4 - Viking Therapeutics, Inc. (0001607678) (Issuer)
- Chief Financial Officer Zante Greg exercised 94,001 shares at a strike of $7.49 and sold $10,089,164 worth of shares (131,687 units at $76.61), decreasing direct ownership by 20% to 149,366 units (SEC Form 4)4 - Viking Therapeutics, Inc. (0001607678) (Issuer)
- Director Rouan Sarah Kathryn exercised 11,000 shares at a strike of $4.88 and sold $889,790 worth of shares (11,000 units at $80.89) (SEC Form 4)4 - Viking Therapeutics, Inc. (0001607678) (Issuer)
- Director Singleton J Matthew exercised 16,000 shares at a strike of $4.48 and sold $1,272,000 worth of shares (16,000 units at $79.50) (SEC Form 4)4 - Viking Therapeutics, Inc. (0001607678) (Issuer)
- Director Singleton J Matthew exercised 10,300 shares at a strike of $1.19 and sold $715,850 worth of shares (10,300 units at $69.50) (SEC Form 4)4 - Viking Therapeutics, Inc. (0001607678) (Issuer)
- President & CEO Lian Brian exercised 166,130 shares at a strike of $7.77 and sold $15,308,553 worth of shares (216,130 units at $70.83), decreasing direct ownership by 2% to 2,304,927 units (SEC Form 4)4 - Viking Therapeutics, Inc. (0001607678) (Issuer)
- President & CEO Lian Brian exercised 1,000 shares at a strike of $7.77 and sold $69,900 worth of shares (1,000 units at $69.90) (SEC Form 4)4 - Viking Therapeutics, Inc. (0001607678) (Issuer)
- Director Singleton J Matthew exercised 5,700 shares at a strike of $1.19 and sold $397,430 worth of shares (5,700 units at $69.72) (SEC Form 4)4 - Viking Therapeutics, Inc. (0001607678) (Issuer)
- President & CEO Lian Brian sold $7,426,508 worth of shares (112,870 units at $65.80) and exercised 112,870 shares at a strike of $7.77 (SEC Form 4)4 - Viking Therapeutics, Inc. (0001607678) (Issuer)
- Director Singleton J Matthew exercised 16,000 shares at a strike of $3.33 and sold $995,453 worth of shares (16,000 units at $62.22) (SEC Form 4)4 - Viking Therapeutics, Inc. (0001607678) (Issuer)
- Director Singleton J Matthew exercised 20,786 shares at a strike of $8.00 and sold $1,195,736 worth of shares (20,786 units at $57.53) (SEC Form 4)4 - Viking Therapeutics, Inc. (0001607678) (Issuer)
- Chief Operating Officer Mancini Marianna was granted 31,667 shares and sold $1,029,912 worth of shares (18,026 units at $57.13), increasing direct ownership by 4% to 362,149 units (SEC Form 4)4 - Viking Therapeutics, Inc. (0001607678) (Issuer)
- Chief Financial Officer Zante Greg was granted 28,334 shares and sold $922,212 worth of shares (16,136 units at $57.15), increasing direct ownership by 7% to 187,052 units (SEC Form 4)4 - Viking Therapeutics, Inc. (0001607678) (Issuer)
- President & CEO Lian Brian was granted 204,333 shares and sold $6,670,604 worth of shares (115,859 units at $57.58), increasing direct ownership by 4% to 2,354,927 units (SEC Form 4)4 - Viking Therapeutics, Inc. (0001607678) (Issuer)
- Zante Greg exercised 34,249 shares at a strike of $4.86 and sold $4,986,008 worth of shares (66,756 units at $74.69), decreasing direct ownership by 16% to 174,854 units (SEC Form 4)4 - Viking Therapeutics, Inc. (0001607678) (Issuer)
- Mancini Marianna exercised 281,425 shares at a strike of $6.18 and sold $22,136,474 worth of shares (281,425 units at $78.66) (SEC Form 4)4 - Viking Therapeutics, Inc. (0001607678) (Issuer)
- Mancini Marianna was granted 31,667 shares and covered exercise/tax liability with 16,610 shares, increasing direct ownership by 4% to 363,565 units (SEC Form 4)4 - Viking Therapeutics, Inc. (0001607678) (Issuer)
- Lian Brian was granted 221,667 shares and covered exercise/tax liability with 153,948 shares, increasing direct ownership by 3% to 2,266,453 units (SEC Form 4)4 - Viking Therapeutics, Inc. (0001607678) (Issuer)
- Zante Greg was granted 31,667 shares and covered exercise/tax liability with 16,610 shares, increasing direct ownership by 8% to 207,361 units (SEC Form 4)4 - Viking Therapeutics, Inc. (0001607678) (Issuer)
- Lian Brian was granted 221,667 shares and covered exercise/tax liability with 162,815 shares, increasing direct ownership by 3% to 2,198,734 units (SEC Form 4)4 - Viking Therapeutics, Inc. (0001607678) (Issuer)
- Mancini Marianna was granted 31,667 shares and covered exercise/tax liability with 16,958 shares, increasing direct ownership by 4% to 348,508 units (SEC Form 4)4 - Viking Therapeutics, Inc. (0001607678) (Issuer)
- Zante Greg was granted 31,667 shares and covered exercise/tax liability with 20,093 shares, increasing direct ownership by 6% to 192,304 units (SEC Form 4)4 - Viking Therapeutics, Inc. (0001607678) (Issuer)
- Lian Brian sold $1,345,500 worth of shares (45,000 units at $29.90), decreasing direct ownership by 2% to 2,139,882 units (SEC Form 4)4 - Viking Therapeutics, Inc. (0001607678) (Issuer)
- Lian Brian exercised 189,079 shares at a strike of $3.76 and sold $7,230,784 worth of shares (269,079 units at $26.87), decreasing direct ownership by 4% to 2,184,882 units (SEC Form 4)4 - Viking Therapeutics, Inc. (0001607678) (Issuer)
- Rouan Sarah Kathryn exercised 25,000 shares at a strike of $8.32 and sold $701,250 worth of shares (25,000 units at $28.05) (SEC Form 4)4 - Viking Therapeutics, Inc. (0001607678) (Issuer)
- Lian Brian exercised 85,000 shares at a strike of $1.23 and sold $2,100,750 worth of shares (85,000 units at $24.71) (SEC Form 4)4 - Viking Therapeutics, Inc. (0001607678) (Issuer)
- Lian Brian exercised 35,000 shares at a strike of $1.23 and sold $838,250 worth of shares (35,000 units at $23.95) (SEC Form 4)4 - Viking Therapeutics, Inc. (0001607678) (Issuer)
- Rouan Sarah Kathryn exercised 30,000 shares at a strike of $8.32 and sold $691,500 worth of shares (30,000 units at $23.05) (SEC Form 4)4 - Viking Therapeutics, Inc. (0001607678) (Issuer)
- Lian Brian covered exercise/tax liability with 254,192 shares and was granted 310,000 shares, increasing direct ownership by 3% to 2,264,882 units (SEC Form 4)4 - Viking Therapeutics, Inc. (0001607678) (Issuer)